Literature DB >> 28778343

Economic Impact of an Enhanced Recovery Pathway for Lung Resection.

Philippe Paci1, Amin Madani1, Lawrence Lee1, Juan Mata1, David S Mulder2, Jonathan Spicer2, Lorenzo E Ferri2, Liane S Feldman3.   

Abstract

BACKGROUND: Multimodal enhanced recovery pathways (ERP) improve clinical outcomes and hospital length of stay for patients undergoing lung resection. However, data supporting their economic impact is lacking. This study evaluated the effect of an ERP on costs of lung resection.
METHODS: Adult patients undergoing elective lung resection from August 2011 to August 2013 at a single university-affiliated institution were prospectively recruited. Pneumonectomies and extended resections were excluded. Beginning in September 2012, patients were enrolled in a multimodal ERP. Outcomes were recorded until 90 days after discharge. Total costs from institutional, health care system, and societal perspectives are reported in 2016 Canadian dollars, with uncertainty expressed as 95% confidence intervals derived using bootstrapped estimates (10,000 repetitions).
RESULTS: The study included 133 patients (conventional care: n = 58; ERP: n = 75). Patient and operative characteristics were similar between the groups. The ERP group had shorter median (interquartile range) length of stay (4 [3 to 6] days vs 6 [4 to 9] days, p < 0.01), decreased total complications (32% vs 52%, p = 0.02), and decreased pulmonary complications (16% vs 34%, p = 0.01), with no difference in readmissions. After discharge, there was a trend towards less caregiver burden for the ERP group (53 ± 90 hours vs 101 ± 252 hours, p = 0.17). Overall societal costs were lower in the ERP group (mean difference per patient: -$4,396 Canadian; 95% confidence interval -$8,674 to $618 Canadian).
CONCLUSIONS: A multidisciplinary ERP is associated with improved clinical outcomes and societal cost savings compared with conventional perioperative management for elective lung resection.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28778343     DOI: 10.1016/j.athoracsur.2017.05.085

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  12 in total

Review 1.  Enhanced recovery after pulmonary surgery.

Authors:  Jules Eustache; Lorenzo E Ferri; Liane S Feldman; Lawrence Lee; Jonathan D Spicer
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

2.  Editorial for economic impact of an enhanced recovery pathway for lung resection.

Authors:  Rajat Kumar; James M Donahue
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

3.  Adding value in healthcare: understanding the whole denominator.

Authors:  Christopher W Seder
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

4.  Enhanced recovery after video-assisted thoracoscopic surgery lobectomy: a prospective, historically controlled, propensity-matched clinical study.

Authors:  Mehdi Tahiri; Eric Goudie; Adeline Jouquan; Jocelyne Martin; Pasquale Ferraro; Moishe Liberman
Journal:  Can J Surg       Date:  2020-05-08       Impact factor: 2.089

5.  Feasibility analysis for the development of a video-assisted thoracoscopic (VATS) lobectomy 23-hour recovery pathway.

Authors:  Teodora-Cristiana Dumitra; Juan-Carlos Molina; Jack Mouhanna; Ioana Nicolau; Stephane Renaud; Ludovic Aubin; Aya Siblini; David Mulder; Lorenzo Ferri; Jonathan Spicer
Journal:  Can J Surg       Date:  2020-07-31       Impact factor: 2.089

6.  Enhanced recovery programs in lung cancer surgery: systematic review and meta-analysis of randomized controlled trials.

Authors:  Shuangjiang Li; Kun Zhou; Guowei Che; Mei Yang; Jianhua Su; Cheng Shen; Pengming Yu
Journal:  Cancer Manag Res       Date:  2017-11-16       Impact factor: 3.989

7.  Impact of an enhanced recovery after surgery pathway on thoracoscopic lobectomy outcomes in non-small cell lung cancer patients: a propensity score-matched study.

Authors:  Céline Forster; Valérie Doucet; Jean Yannis Perentes; Etienne Abdelnour-Berchtold; Matthieu Zellweger; Mohamed Faouzi; Hasna Bouchaab; Solange Peters; Carlo Marcucci; Thorsten Krueger; Lorenzo Rosner; Michel Gonzalez
Journal:  Transl Lung Cancer Res       Date:  2021-01

8.  Morbidity associated with the use of oxaliplatin versus mitomycin C in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal or appendiceal origin: a multi-institutional comparative study.

Authors:  Ella Benzaquen; Yifan Wang; Stephanie Wiseman; Velka Rosenfeld; Lucas Sideris; Pierre Dubé; Jean-Sebastien Pelletier; Tsafrir Vanounou
Journal:  Can J Surg       Date:  2021-03-02       Impact factor: 2.089

9.  An enhanced recovery after surgery program for video-assisted thoracoscopic surgery anatomical lung resections is cost-effective.

Authors:  Michel Gonzalez; Etienne Abdelnour-Berchtold; Jean Yannis Perentes; Valérie Doucet; Mathieu Zellweger; Carlos Marcucci; Hans-Beat Ris; Thorsten Krueger; Fabrizio Gronchi
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

10.  Enhanced Recovery After Surgery Protocol Minimizes Intensive Care Unit Utilization and Improves Outcomes Following Pulmonary Resection.

Authors:  Terrance Peng; Kimberly A Shemanski; Li Ding; Elizabeth A David; Anthony W Kim; Michael Kim; Dustin K Lieu; Sean C Wightman; Jasmine Zhao; Scott M Atay
Journal:  World J Surg       Date:  2021-08-04       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.